The Management of Chronic Heart Failure and Hypertension

Dear Colleagues,

The ever-increasing life span of the global human population is leading to a new epidemiology of chronic conditions and, in particular, cardiovascular conditions. Indeed, the number of patients with hypertension and chronic heart failure are increasing, and healthcare systems are starting to fail in providing the traditional paradigms of care. New horizons are therefore being created—where innovation is the keyword—in an attempt to find new targets of disease, new therapies, new models of treatment, and new partners in treatment. Innovation remains the only hope for the future of our patients, of ourselves, and of our children, before the collapse of our model healthcare systems.

With this Special Issue, we wish to provide a glimpse of the future. We expect you to provide your point of view or best results in terms of personalization of diagnosis and risk stratification and as based on “omics” and artificial intelligence. We want to hear about your proposed mechanisms for diseases that have lead to the progression of these conditions towards cardiovascular events; we want to learn how to prevent the progression of hypertension and heart failure, the impact of modern strategies of prevention and treatment based on lifestyles and integrated care; we want to look at the picture of those new technologies, including ICT, mHealth, and eHealth, and what they can capture from the future. In short, we challenge you to provide your best, boldest, visionary science to this issue to help us to understand the new horizons into which we are sailing.

Prof. Dr. Guido Iaccarino
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.